Stock A041910 POLARIS AI PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Polaris AI Pharma Corp.

Equities

A041910

KR7041910001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
9,110 KRW -2.04% Intraday chart for Polaris AI Pharma Corp. -6.28% +32.03%
Mar. 27 Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. completed the acquisition of 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae. CI
Feb. 29 Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. agreed to acquire 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae for KRW 40 billion. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. completed the acquisition of 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae.
CI
Polaris Office Corp., Leenos Corp., Sewon Co.,Ltd and POLARIS UNO, Inc. agreed to acquire 20% stake in EstechPharma Co., Ltd. from Jae-cheol Kim and Seon-hee Bae for KRW 40 billion.
CI
EstechPharma Co., Ltd.(KOSDAQ:A041910) dropped from S&P Global BMI Index
CI
Vivozon Inc. announced that it has received KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.
CI
Vivozon, Inc. announced that it expects to receive KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.
CI
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 12, 2016.
CI
EstechPharma Co., Ltd.'s Equity Buyback announced on December 12, 2016, has expired with 106,086 shares, representing 0.94% for KRW 1,054.08 million.
CI
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 12, 2016.
CI
EstechPharma Co., Ltd. authorizes a Buyback Plan.
CI
EstechPharma Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
EstechPharma Co., Ltd.(KOSDAQ:A041910) added to S&P Global BMI Index
CI
Vivozon, Inc. announced that it has received KRW 2 billion in funding from EstechPharma Co., Ltd.
CI
Vivozon, Inc. announced that it expects to receive KRW 2 billion in funding from EstechPharma Co., Ltd.
CI
Tranche Update on EstechPharma Co., Ltd.'s Equity Buyback Plan announced on December 5, 2013.
CI
EstechPharma Co., Ltd.'s Equity Buyback announced on December 5, 2013 has closed with 110,619 shares for KRW 950.06 million.
CI
EstechPharma Co., Ltd. announces an Equity Buyback for 110,619 shares, for KRW 1,000 million.
CI
EstechPharma Co., Ltd. authorizes a Buyback Plan.
CI
Korea Securities Finance Corporation acquired 4.06% stake in EstechPharma Co., Ltd..
CI
Estechpharma Co. Ltd. announced that it has received KRW 4 billion in funding.
CI
Estechpharma Co. Ltd. announced that it expects to receive KRW 4 billion in funding.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A041910 Stock
  4. News Polaris AI Pharma Corp.